GlassScriptPhysician profile
Joshua Mares
NPI 1205397452
$18,941.58
in general payments reported to CMS, 2019-2025
6 companies · $9,874 in 2025
The $9,874 reported for 2025 was more than what 76% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,069 · 2023: $450 · 2024: $4,549 · 2025: $9,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $7,500 · Travel and Lodging: $4,828 · Food and Beverage: $2,203 · Education: $261 · Entertainment: $81.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $7,500.00 |
| Travel and Lodging | $4,828.07 |
| Food and Beverage | $2,202.56 |
| Education | $261.00 |
| Entertainment | $81.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,723.88 | 2024-2025 | Evos, Evos Mini, Maverick |
| Ortho Development Corporation | $5,090.75 | 2025 | |
| Stryker Corporation | $3,310.55 | 2022-2025 | Mako, Axsos, Vitoss |
| Gemini Mountain Medical, LLC | $2,400.00 | 2022 | |
| Medical Device Business Services, INC. | $261.00 | 2024 | |
| Cerapedics INC. | $155.40 | 2023 | I-Factor Peptide Enhanced Bone Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Mares listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.